Breaking News Instant updates and real-time market news.

FET

Forum Energy

$0.48 /

-0.0014 (-0.29%)

07:33
10/30/20
10/30
07:33
10/30/20
07:33

Forum Energy announces 1-for-20 reverse stock split to regain NYSE compliance

Forum Energy announced that its board has approved a 1-for-20 reverse stock split of the company's issued and outstanding shares of common stock, par value 1c per share, accompanied by a corresponding decrease in the company's authorized shares of common stock, such that, following the consummation of the reverse stock split, the number of authorized shares of common stock will be reduced from 296,000,000 to 14,800,000. The company's stockholders previously approved the reverse stock split at the annual meeting of stockholders on May 12. The reverse stock split will be affected pursuant to an amendment to the company's third amended and restated certificate of incorporation filed with the Secretary of State of the State of Delaware. The company anticipates that the effective time of the reverse stock split will be after market close on November 9, with the common stock trading on a post-split basis under the company's existing trading symbol at the market open on November 10 with a new CUSIP number. The reverse stock split will increase the market price per share of the company's common stock, bringing the company into compliance with the listing requirements of the New York Stock Exchange. As a result of the reverse stock split, every 20 pre-split shares of common stock outstanding will automatically combine into one new share of common stock without any action on the part of the holders, and the number of outstanding common shares will be reduced from approximately 111.5M shares to approximately 5.6M shares.

  • 06

    Nov

FET Forum Energy
$0.48 /

-0.0014 (-0.29%)

06/30/20
Fly Intel: Top five analyst downgrades
06/29/20 Piper Sandler
Forum Energy downgraded to Neutral from Overweight at Piper Sandler
03/19/20 Barclays
Forum Energy downgraded to Underweight from Equal Weight at Barclays
03/16/20 Morgan Stanley
Forum Energy downgraded to Underweight from Equal Weight at Morgan Stanley

TODAY'S FREE FLY STORIES

Hot Stocks
XpresSpa names David Kohel as its CTO » 16:07
12/01/20
12/01
16:07
12/01/20
16:07
XSPA

XpresSpa

$1.50 /

-0.14 (-8.54%)

XpresSpa announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XSPA XpresSpa
$1.50 /

-0.14 (-8.54%)

XSPA XpresSpa
$1.50 /

-0.14 (-8.54%)

XSPA XpresSpa
$1.50 /

-0.14 (-8.54%)

XSPA XpresSpa
$1.50 /

-0.14 (-8.54%)

Earnings
HP Enterprise sees FY21 adjusted EPS $1.60-$1.78, consensus $1.54 » 16:07
12/01/20
12/01
16:07
12/01/20
16:07
HPE

HP Enterprise

$11.29 /

+0.26 (+2.36%)

Fiscal 2021 non-GAAP…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

11/16/20
Fly Intel: Top five analyst upgrades
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
09/22/20 UBS
HP Enterprise assumed with a Neutral at UBS
HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

Hot Stocks
Galapagos announces 1st dosing in Mangrove trial in GLPG2737 with ADPKD patient » 16:07
12/01/20
12/01
16:07
12/01/20
16:07
GLPG

Galapagos

$127.36 /

+4.56 (+3.71%)

Galapagos NV announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GLPG Galapagos
$127.36 /

+4.56 (+3.71%)

GLPG Galapagos
$127.36 /

+4.56 (+3.71%)

11/23/20 UBS
Galapagos price target lowered to EUR 116 from EUR 125 at UBS
11/19/20 Maxim
Galapagos initiated with a Buy at Maxim
11/12/20 JPMorgan
Galapagos price target lowered to EUR 120 from EUR 130 at JPMorgan
11/12/20 JPMorgan
Galapagos price target lowered to $142 from $152 at JPMorgan
GLPG Galapagos
$127.36 /

+4.56 (+3.71%)

GLPG Galapagos
$127.36 /

+4.56 (+3.71%)

Hot Stocks
Salesforce to acquire Slack in cash and stock for enterprise value of $27.7B » 16:07
12/01/20
12/01
16:07
12/01/20
16:07
CRM

Salesforce

$241.67 /

-4.6 (-1.87%)

Salesforce (CRM) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$241.67 /

-4.6 (-1.87%)

CRM Salesforce
$241.67 /

-4.6 (-1.87%)

11/30/20 Barclays
Barclays sees limited upside for Slack after rally, downgrades shares
11/27/20 Morgan Stanley
Salesforce deal for Slack would likely be dilutive, says Morgan Stanley
11/27/20 DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
11/27/20 Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
CRM Salesforce
$241.67 /

-4.6 (-1.87%)

CRM Salesforce
$241.67 /

-4.6 (-1.87%)

CRM Salesforce
$241.67 /

-4.6 (-1.87%)

CRM Salesforce
$241.67 /

-4.6 (-1.87%)

Recommendations
Agios' success 'bodes well' for ACTIVATE-T trial, says Oppenheimer » 16:07
12/01/20
12/01
16:07
12/01/20
16:07
AGIO

Agios Pharmaceuticals

$46.58 /

+0.27 (+0.58%)

After Agios announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGIO Agios Pharmaceuticals
$46.58 /

+0.27 (+0.58%)

AGIO Agios Pharmaceuticals
$46.58 /

+0.27 (+0.58%)

11/20/20 Barclays
Agios Pharmaceuticals price target raised to $50 from $46 at Barclays
11/19/20 Piper Sandler
Piper continues to like setup for Agios Pharmaceuticals shares into ASH
11/19/20 Cantor Fitzgerald
Agios Pharmaceuticals price target raised to $79 from $68 at Cantor Fitzgerald
10/22/20 Barclays
Agios upgraded to Overweight with $46 target at Barclays
AGIO Agios Pharmaceuticals
$46.58 /

+0.27 (+0.58%)

AGIO Agios Pharmaceuticals
$46.58 /

+0.27 (+0.58%)

Earnings
HP Enterprise sees Q1 adjusted EPS 40c-44c, consensus 35c » 16:06
12/01/20
12/01
16:06
12/01/20
16:06
HPE

HP Enterprise

$11.27 /

+0.235 (+2.13%)

Fiscal 2021 first quarter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

11/16/20
Fly Intel: Top five analyst upgrades
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
09/22/20 UBS
HP Enterprise assumed with a Neutral at UBS
HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

HPE HP Enterprise
$11.27 /

+0.235 (+2.13%)

Hot Stocks
Agree Realty raises dividend 6% to 62c » 16:06
12/01/20
12/01
16:06
12/01/20
16:06
ADC

Agree Realty

$66.29 /

+0.39 (+0.59%)

The Board of Directors…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADC Agree Realty
$66.29 /

+0.39 (+0.59%)

ADC Agree Realty
$66.29 /

+0.39 (+0.59%)

10/12/20 BTIG
Agree Realty initiated with a Buy at BTIG
09/29/20 Mizuho
Agree Realty initiated with a Buy at Mizuho
07/02/20 Citi
Agree Realty price target raised to $76 from $70 at Citi
06/10/20 Wells Fargo
Agree Realty price target raised to $75 from $67 at Wells Fargo
ADC Agree Realty
$66.29 /

+0.39 (+0.59%)

  • 31
    Mar
Hot Stocks
HP Enterprise to relocate headquarters to Houston, Texas » 16:06
12/01/20
12/01
16:06
12/01/20
16:06
HPE

HP Enterprise

$11.29 /

+0.26 (+2.36%)

HPE has made the decision…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

11/16/20
Fly Intel: Top five analyst upgrades
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
09/22/20 UBS
HP Enterprise assumed with a Neutral at UBS
HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

Syndicate
Reata Pharmaceuticals announces offering of 2M shares of Class A common stock » 16:06
12/01/20
12/01
16:06
12/01/20
16:06
RETA

Reata Pharmaceuticals

$151.36 /

-1.21 (-0.79%)

Reata Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$151.36 /

-1.21 (-0.79%)

RETA Reata Pharmaceuticals
$151.36 /

-1.21 (-0.79%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
RETA Reata Pharmaceuticals
$151.36 /

-1.21 (-0.79%)

RETA Reata Pharmaceuticals
$151.36 /

-1.21 (-0.79%)

Earnings
HP Enterprise reports Q4 adjusted EPS 37c, consensus 34c » 16:05
12/01/20
12/01
16:05
12/01/20
16:05
HPE

HP Enterprise

$11.29 /

+0.26 (+2.36%)

Reports Q4 revenue $7.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

11/16/20
Fly Intel: Top five analyst upgrades
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
11/16/20 Raymond James
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
09/22/20 UBS
HP Enterprise assumed with a Neutral at UBS
HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

HPE HP Enterprise
$11.29 /

+0.26 (+2.36%)

Hot Stocks
Tredegar declares special dividend of $5.97 per share » 16:05
12/01/20
12/01
16:05
12/01/20
16:05
TG

Tredegar

$16.60 /

+0.85 (+5.40%)

Tredegar announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TG Tredegar
$16.60 /

+0.85 (+5.40%)

Conference/Events
AdaptHealth participates in a conference call with Jefferies » 16:05
12/01/20
12/01
16:05
12/01/20
16:05
AHCO

AdaptHealth

$35.45 /

+5.61 (+18.80%)

Healthcare Equity…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AHCO AdaptHealth
$35.45 /

+5.61 (+18.80%)

AHCO AdaptHealth
$35.45 /

+5.61 (+18.80%)

11/17/20 Deutsche Bank
AdaptHealth price target raised to $36 from $26 at Deutsche Bank
11/16/20 Baird
AdaptHealth initiated with an Outperform at Baird
11/05/20 SVB Leerink
AdaptHealth price target raised to $32.50 from $23.50 at SVB Leerink
08/11/20 RBC Capital
AdaptHealth price target raised to $33 from $24 at RBC Capital
AHCO AdaptHealth
$35.45 /

+5.61 (+18.80%)

  • 03
    Sep
  • 01
    Jul
AHCO AdaptHealth
$35.45 /

+5.61 (+18.80%)

Hot Stocks
NetApp CEO says company 'uniquely positioned' to help w/ digital transformations » 16:04
12/01/20
12/01
16:04
12/01/20
16:04
NTAP

NetApp

$54.24 /

+0.97 (+1.82%)

CEO George Kurian says:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTAP NetApp
$54.24 /

+0.97 (+1.82%)

NTAP NetApp
$54.24 /

+0.97 (+1.82%)

11/30/20 Deutsche Bank
NetApp price target raised to $50 from $45 at Deutsche Bank
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
10/29/20 OTR Global
NetApp upgraded to Mixed from Negative at OTR Global
NTAP NetApp
$54.24 /

+0.97 (+1.82%)

NTAP NetApp
$54.24 /

+0.97 (+1.82%)

NTAP NetApp
$54.24 /

+0.97 (+1.82%)

NTAP NetApp
$54.24 /

+0.97 (+1.82%)

Hot Stocks
Oyster Point Pharma submits OC-01 nasal spray trial protocol to FDA » 16:03
12/01/20
12/01
16:03
12/01/20
16:03
OYST

Oyster Point Pharma

$21.45 /

+0.08 (+0.37%)

Oyster Point Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OYST Oyster Point Pharma
$21.45 /

+0.08 (+0.37%)

OYST Oyster Point Pharma
$21.45 /

+0.08 (+0.37%)

08/05/20 Piper Sandler
Oyster Point Pharma remains 'fundamentally undervalued,' says Piper Sandler
05/13/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Kala after 'underwhelming' competitor data
05/11/20 Piper Sandler
Piper says Oyster Point 'highly likely' to get dry eye approval, superior label
03/30/20 Piper Sandler
Oyster Point ONSET-2 trial barely impacted by COVID-19, says Piper Sandler
OYST Oyster Point Pharma
$21.45 /

+0.08 (+0.37%)

  • 15
    May
Earnings
NetApp sees Q3 EPS 94c-$1.02, consensus 89c  16:03
12/01/20
12/01
16:03
12/01/20
16:03
NTAP

NetApp

$54.20 /

+0.93 (+1.75%)

 
ShowHide Related Items >><<
NTAP NetApp
$54.20 /

+0.93 (+1.75%)

NTAP NetApp
$54.20 /

+0.93 (+1.75%)

11/30/20 Deutsche Bank
NetApp price target raised to $50 from $45 at Deutsche Bank
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
10/29/20 OTR Global
NetApp upgraded to Mixed from Negative at OTR Global
NTAP NetApp
$54.20 /

+0.93 (+1.75%)

NTAP NetApp
$54.20 /

+0.93 (+1.75%)

NTAP NetApp
$54.20 /

+0.93 (+1.75%)

NTAP NetApp
$54.20 /

+0.93 (+1.75%)

Syndicate
Twist Bioscience files to sell $325M in common stock » 16:02
12/01/20
12/01
16:02
12/01/20
16:02
TWST

Twist Bioscience

$118.29 /

+6.06 (+5.40%)

Twist Bioscience…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWST Twist Bioscience
$118.29 /

+6.06 (+5.40%)

TWST Twist Bioscience
$118.29 /

+6.06 (+5.40%)

11/24/20 SVB Leerink
Twist Bioscience price target raised to $100 from $90 at SVB Leerink
11/24/20 Baird
Twist Bioscience price target raised to $125 from $70 at Baird
10/20/20 SVB Leerink
Twist Bioscience initiated with a Market Perform at SVB Leerink
02/06/20 Cowen
Developments in Agilent-Twist dispute could mean settlement imminent, says Cowen
TWST Twist Bioscience
$118.29 /

+6.06 (+5.40%)

  • 04
    Jun
  • 20
    Feb
TWST Twist Bioscience
$118.29 /

+6.06 (+5.40%)

Earnings
Vapotherm raises FY20 revenue view to $114.8M-$117.8M, consensus $103.91M » 16:02
12/01/20
12/01
16:02
12/01/20
16:02
VAPO

Vapotherm

$25.01 /

-0.12 (-0.48%)

Previous view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

11/05/20 Canaccord
Vapotherm price target lowered to $40 from $54 at Canaccord
07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

  • 07
    May
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

Earnings
NetApp reports Q2 EPS $1.05, consensus 73c » 16:02
12/01/20
12/01
16:02
12/01/20
16:02
NTAP

NetApp

$54.15 /

+0.88 (+1.65%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTAP NetApp
$54.15 /

+0.88 (+1.65%)

NTAP NetApp
$54.15 /

+0.88 (+1.65%)

11/30/20 Deutsche Bank
NetApp price target raised to $50 from $45 at Deutsche Bank
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
11/12/20 Wedbush
NetApp initiated with a Neutral at Wedbush
10/29/20 OTR Global
NetApp upgraded to Mixed from Negative at OTR Global
NTAP NetApp
$54.15 /

+0.88 (+1.65%)

NTAP NetApp
$54.15 /

+0.88 (+1.65%)

NTAP NetApp
$54.15 /

+0.88 (+1.65%)

NTAP NetApp
$54.15 /

+0.88 (+1.65%)

Earnings
Vapotherm raises Q4 revenue view to $30M-$33M from $18M-$20M » 16:02
12/01/20
12/01
16:02
12/01/20
16:02
VAPO

Vapotherm

$25.01 /

-0.12 (-0.48%)

Consensus $19.04M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

11/05/20 Canaccord
Vapotherm price target lowered to $40 from $54 at Canaccord
07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

  • 07
    May
VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

VAPO Vapotherm
$25.01 /

-0.12 (-0.48%)

Conference/Events
Credit Suisse healthcare analysts to hold analyst/industry conference call » 15:59
12/01/20
12/01
15:59
12/01/20
15:59

Analysts, along with Dr.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Periodicals
CoreLogic interest seen being 'strong,' CTFN reports » 15:56
12/01/20
12/01
15:56
12/01/20
15:56
CLGX

CoreLogic

$78.02 /

+0.515 (+0.66%)

CTFN's Diane Alter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$78.02 /

+0.515 (+0.66%)

CLGX CoreLogic
$78.02 /

+0.515 (+0.66%)

07:34 Today Truist
CoreLogic downgraded to Hold from Buy at Truist
06:45 Today Truist
CoreLogic downgraded to Hold from Buy at Truist
10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
09/22/20 Truist
CoreLogic increasingly likely to see other financial suitors, says Truist
CLGX CoreLogic
$78.02 /

+0.515 (+0.66%)

CLGX CoreLogic
$78.02 /

+0.515 (+0.66%)

CLGX CoreLogic
$78.02 /

+0.515 (+0.66%)

Hot Stocks
Tredegar trading halted, news pending  15:45
12/01/20
12/01
15:45
12/01/20
15:45
TG

Tredegar

$16.68 /

+0.925 (+5.87%)

 
ShowHide Related Items >><<
TG Tredegar
$16.68 /

+0.925 (+5.87%)

Options
Fitbit call volume above normal and directionally bullish » 15:45
12/01/20
12/01
15:45
12/01/20
15:45
FIT

Fitbit

$7.22 /

+0.04 (+0.56%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FIT Fitbit
$7.22 /

+0.04 (+0.56%)

FIT Fitbit
$7.22 /

+0.04 (+0.56%)

06/19/20 Deutsche Bank
Fitbit acquisition completing remains base case at Deutsche Bank
FIT Fitbit
$7.22 /

+0.04 (+0.56%)

FIT Fitbit
$7.22 /

+0.04 (+0.56%)

FIT Fitbit
$7.22 /

+0.04 (+0.56%)

FIT Fitbit
$7.22 /

+0.04 (+0.56%)

Periodicals
CTFN publishes report on CoreLogic auction plans » 15:42
12/01/20
12/01
15:42
12/01/20
15:42
CLGX

CoreLogic

$77.90 /

+0.3951 (+0.51%)

, CNNE

Cannae Holdings

$40.52 /

+1.16 (+2.95%)

CTFN's Diane Alter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$77.90 /

+0.3951 (+0.51%)

CNNE Cannae Holdings
$40.52 /

+1.16 (+2.95%)

CLGX CoreLogic
$77.90 /

+0.3951 (+0.51%)

07:34 Today Truist
CoreLogic downgraded to Hold from Buy at Truist
06:45 Today Truist
CoreLogic downgraded to Hold from Buy at Truist
10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
09/22/20 Truist
CoreLogic increasingly likely to see other financial suitors, says Truist
CNNE Cannae Holdings
$40.52 /

+1.16 (+2.95%)

11/19/20 Oppenheimer
Cannae Holdings initiated with an Outperform at Oppenheimer
09/22/20 Truist
CoreLogic increasingly likely to see other financial suitors, says Truist
06/26/20 SunTrust
CoreLogic upgraded to Buy from Hold at SunTrust
05/14/20 Stephens
Cannae Holdings price target raised to $43 from $40 at Stephens
CLGX CoreLogic
$77.90 /

+0.3951 (+0.51%)

  • 11
    Jun
  • 04
    Dec
CLGX CoreLogic
$77.90 /

+0.3951 (+0.51%)

CNNE Cannae Holdings
$40.52 /

+1.16 (+2.95%)

CLGX CoreLogic
$77.90 /

+0.3951 (+0.51%)

CNNE Cannae Holdings
$40.52 /

+1.16 (+2.95%)

Options
Box options imply 14.0% move in share price post-earnings » 15:34
12/01/20
12/01
15:34
12/01/20
15:34
BOX

Box

$18.54 /

-0.14 (-0.75%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOX Box
$18.54 /

-0.14 (-0.75%)

BOX Box
$18.54 /

-0.14 (-0.75%)

08/27/20 Craig-Hallum
Box price target raised to $30 from $24 at Craig-Hallum
08/27/20 Morgan Stanley
Box has large, attractive market opportunity, says Morgan Stanley
05/28/20 Raymond James
Box price target raised to $24 from $18 at Raymond James
05/28/20 Craig-Hallum
Box upgraded to Buy at Craig-Hallum on improved execution, net expansion
BOX Box
$18.54 /

-0.14 (-0.75%)

BOX Box
$18.54 /

-0.14 (-0.75%)

BOX Box
$18.54 /

-0.14 (-0.75%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.